Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
174 participants
INTERVENTIONAL
2012-03-31
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Adults with obesity and health problems in primary health care are invited to be part of the study. The geographical area is Orebro county which has in all 29 primary health care centers. Population is 276 000, and according to population studies around 15% of the adult population has a BodyMassIndex (BMI) over 30, which is characterized as obesity according to WHO.
Specific objectives are;
* To evaluate if internet-based CBT treatment after LCD improves weight stability after 1 and 2 years.
* To evaluate if weight loss improves metabolic parameters such as HbA1c, blood glucose, Cholesterol, Low density lipoproteins (LDL),High density lipoproteins (HDL) , triglycerides (TG) and Bloodpressure (BP)
* To evaluate weight loss influence on quality of life, body pain, eating behavior, obesity related problems, fatigue and mood, and to see if CBT program for weight stability also improves these factors
* To evaluate if LCD treatment is a possible treatment for obesity in ordinary primary health care
Patients taking part in the study, undergo a 12 week period of Low Calorie Diet (LCD) treatment, followed by a 12 week reintroduction to ordinary food. During this period the patient has contact with the primary health care nurse and doctor. After 24 weeks of treatment, the patient who follows the study is supposed to have lost around 10% of initial weight.All patients losing more than 7% weight during the first 24 weeks, are randomized to either ordinary follow up (group 1) or an internet-based CBT programme for weight stability (group 2). All patients in the study are followed at 1 year by doctor, and at 2 year by nurse visit.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interventions for Lifestyle Changes to Promote Weight Reduction, a Randomized Controlled Trial in Primary Health Care
NCT01606917
The Effect and Applicability of CBT-Based Weight Loss Treatment Model in Obese Patients With Comorbid Depression in Health Care
NCT04513587
Weight Loss in Adults With Obesity Using a Combination of Low Energy Diet, Group Treatment and Intragastric Balloon
NCT04230655
Internet Treatment for Patients With Obesity
NCT05149950
CBT-based and Motivational Interviewing Supported Psychoeducation in Obese Individuals
NCT06632171
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients are given brief information at ordinary visits at doctor, nurse or physiotherapists, or by written information announced at the health care center. Before going into the study they need a doctors visit to pass the inclusion and exclusion criteria. The study starts at a nurse visit where the patient gets written information about the LCD treatment and the protocol.
After 24 weeks in the study, all patients with weight loss of 7% or more are randomized into two groups.
Group 1, keep their contact with the nurse at the primary health care centre, and gets a written prescription of physical activity, which is followed by a visit at 36 weeks.
Group 2, gets a code for the internet-based CBT programme. They go into the programme at home, and follow the programme which has the goal of weight stability and contains strategies of meal plans, portion controls, physical activity planning, and cognitive strategies of thinking and goal setting. During this programme there is an opportunity to "chat" with CBT therapists via the internet, concerning the programme and its challenges. No personal meeting with therapist is included.
At 1 year in the study both groups meed with doctor at primary health care center and at 2 year there is a nurse follow up at the same center.
At baseline, 12 weeks, 24 weeks, 1 year and 2 years several validated instruments are used to follow patients wellbeing due to:
* Quality of life (Short Form -36, SF-36)
* Obesity related problems (Obesity related Problems Scale version 3 OPv3)
* Mood (Mood Adjective Chek List MACL)
* Self reported pain (Brief Pain Inventory Short form BPI-SF)
* Eating behavior (Three Factor Eating Questionnaire- Revised 21 Items TFEQ-R21)
* Fatigue (Multidimensional Fatigue Inventory MFI)
We also investigate the patients experiences of the treatment, how they manage to hold on to the diet, and how it effects their motivation for ongoing lifestyle changes. For this we use a study specific instrument.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ordinary primary care follow up
Ordinary follow up after 24 weeks of LCD diet + reintroduction of food.
No interventions assigned to this group
CBT follow up
11 weeks intervention programme with CBT conducted via internet.
CBT follow up
11 weeks programme conducted via internet. CBT with focus on weight stability.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBT follow up
11 weeks programme conducted via internet. CBT with focus on weight stability.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Access to the internet and the ability to read and understand written information in swedish.
Exclusion Criteria
* Excessive eating disorder problems (screening forms are used)
* Severe heart failure (New York Heart Association (NYHA) class III-IV)
* Moderate or severe COPD (Chronic Obstructive Pulmonary Disease) (FEV% \<50)
* Uncontrolled asthma (hospitalization or more than twice requiring inhalation treatment on health care site last year)
* Pregnancy and lactation
* Type 1 Diabetes
* Serious liver dysfunction (ALT value more than doubled, women\> 1.5 μkat / L, men\> 2.2 μkat / L)
* Former Gastric bypass surgery or other weight reducing surgery
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Örebro County Council
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jan Karlsson
Behaviorist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jan Karlsson
Role: PRINCIPAL_INVESTIGATOR
Universitetssjukvårdens forskningscentrum, UFC, Region Örebro län, Box 1613, 70116 Örebro
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Orebro County Council
Örebro, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011/434
Identifier Type: OTHER
Identifier Source: secondary_id
OCC-LCD-PV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.